Health Catalyst, Inc. (HCAT) |
| 1.85 0.21 (12.8%) 06-12 16:00 |
| Open: | 1.67 |
| High: | 1.86 |
| Low: | 1.575 |
| Volume: | 1,371,641 |
| Market Cap: | 137(M) |
| PE Ratio: | -0.5 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 2.60 |
| Resistance 1: | 2.23 |
| Pivot price: | 1.54 |
| Support 1: | 1.54 |
| Support 2: | 1.12 |
| 52w High: | 4.125 |
| 52w Low: | 0.955 |
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
| EPS | -3.730 |
| Book Value | 1.870 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.065 |
| Profit Margin (%) | -87.70 |
| Operating Margin (%) | -9.54 |
| Return on Assets (ttm) | -3.5 |
| Return on Equity (ttm) | -103.0 |
Wed, 10 Jun 2026
Health Catalyst (HCAT) Form 144: 34,485 restricted shares planned sale 06/10/2026 - Stock Titan
Mon, 08 Jun 2026
Whetstone updates Health Catalyst (HCAT) ownership to 4.5% stake - Stock Titan
Sun, 07 Jun 2026
Health Catalyst, Inc. - MLQ.ai
Thu, 04 Jun 2026
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware - Latham & Watkins LLP
Thu, 04 Jun 2026
HCAT Stock Jumps As Strategic Reset Follows Earnings Beat - StocksToTrade
Wed, 03 Jun 2026
Health Catalyst (HCAT) CFO mandated share sale to cover RSU taxes - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |